Next Article in Journal
Midkine: A Novel Prognostic Biomarker for Cancer
Next Article in Special Issue
Acral Lentiginous Melanoma in Situ: A Diagnostic and Management Challenge
Previous Article in Journal
Galectins as Cancer Biomarkers
Previous Article in Special Issue
Management of Melanoma Families
Article Menu

Export Article

Open AccessArticle
Cancers 2010, 2(2), 611-623; doi:10.3390/cancers2020611

The NK-1 Receptor Antagonist L-732,138 Induces Apoptosis and Counteracts Substance P-Related Mitogenesis in Human Melanoma Cell Lines

1
Research Laboratory on Neuropeptides, Virgen del Rocío University Hospital, Sevilla, Spain
2
Institute of Neurosciences of Castilla y León (INCYL), Laboratory of Neuroanatomy of the Peptidergic Systems (Laboratory 14), Salamanca, Spain
*
Author to whom correspondence should be addressed.
Received: 17 March 2010 / Revised: 14 April 2010 / Accepted: 19 April 2010 / Published: 20 April 2010
(This article belongs to the Special Issue Current Concepts in the Diagnosis and Treatment of Cutaneous Melanoma)
View Full-Text   |   Download PDF [382 KB, uploaded 20 April 2010]   |  

Abstract

It has been recently demonstrated that substance P (SP) and neurokinin-1 (NK-1) receptor antagonists induce cell proliferation and cell inhibition in human melanoma cells, respectively. However, the antitumor action of the NK-1 receptor antagonist L-732,138 on such cells is unknown. The aim of this study was to demonstrate an antitumor action of L-732,138 against three human melanoma cell lines (COLO 858, MEL HO, COLO 679). We found that L-732,138 elicits cell growth inhibition in a concentration dependent manner in the melanoma cells studied. Moreover, L-732,138 blocks SP mitogen stimulation. The specific antitumor action of L-732,138 occurred through the NK-1 receptor and melanoma cell death was by apoptosis. These findings indicate that the NK-1 receptor antagonist L-732,138 could be a new antitumor agent in the treatment of human melanoma.
Keywords: melanoma; NK-1 receptor antagonist; L-732,138; antitumor; apoptosis melanoma; NK-1 receptor antagonist; L-732,138; antitumor; apoptosis
Figures

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Muñoz, M.; Rosso, M.; González-Ortega, A.; Coveñas, R. The NK-1 Receptor Antagonist L-732,138 Induces Apoptosis and Counteracts Substance P-Related Mitogenesis in Human Melanoma Cell Lines. Cancers 2010, 2, 611-623.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top